NCT05677581

Brief Summary

The goal of this observational study is to provide a reference for formulating individual appropriate iodine intake programs for women during pregnancy and postpartum and improving the monitoring and evaluation system of maternal iodine nutrition status. The main questions it aims to answer are:

  • To analyse the longitudinal changes of urinary iodine, urinary iodine/creatinine ratio, thyroid function and related factors in different periods of early, middle, late pregnancy and 6 weeks postpartum in Beijing area.
  • To explore the relationship between iodine nutrition status and the changes of thyroid function and to further clarify the effect of iodine nutrition status on thyroid function of women of childbearing age during pregnancy and postpartum in combination with dietary intake of iodine questionnaire. Participants will be detected there thyroid function, the level of median urinary iodine and urinary iodine/creatinine. Researchers will compare healthy women of childbearing age served as the control group in the same period.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,100

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 10, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

November 15, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

May 10, 2024

Status Verified

November 1, 2023

Enrollment Period

1.1 years

First QC Date

November 30, 2022

Last Update Submit

May 8, 2024

Conditions

Outcome Measures

Primary Outcomes (4)

  • Data of pregnant women in the early trimester of pregnancy

    detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary iodine and urinary iodine/creatinine

    Any day between weeks 8 and 12 of gestation

  • Data of pregnant women in the middle trimester of pregnancy

    detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary

    Any day between weeks 24 and 28 of gestation

  • Data of pregnant women in the third trimester of pregnancy

    detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary

    Any day between weeks 36 of gestation to the day before parturition

  • Data of postpartum women

    detect the level of serum TSH, FT4, TPOAb, TGAb and the level of median urinary

    6 weeks after parturition

Study Arms (2)

pregnancy and lactation period women

Other: iodine nutrition status

healthy women of childbearing age

Other: iodine nutrition status

Interventions

iodine nutrition status

healthy women of childbearing agepregnancy and lactation period women

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

maternal and women of childbearing age in Beijing area

You may qualify if:

  • primigravida
  • no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases before pregnancy
  • no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases before pregnancy
  • no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases before pregnancy

You may not qualify if:

  • multiple pregnancies and multigravida
  • a history of type I or type II diabetes before pregnancy
  • a clear history of thyroid diseases before pregnancy
  • taking drugs that affect thyroid function and/or blood sugar before or during early pregnancy
  • Healthy women of childbearing age:
  • years old
  • no chronic hypertension, thromboembolic disease, severe gastrointestinal, cardiopulmonary and liver diseases
  • no systemic lupus erythematosus, rheumatic diseases and other connective tissue diseases or immune diseases
  • no adrenocortical hyperplasia, pituitary endocrine diseases and other diseases
  • a history of type I or type II diabetes
  • a clear history of thyroid diseases
  • taking drugs that affect thyroid function and/or blood sugar

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Friendship Hospital ,Capital Medical University

Beijing, China

RECRUITING

Central Study Contacts

Yan Long, Chief Physician/Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 30, 2022

First Posted

January 10, 2023

Study Start

November 15, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

May 10, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations